FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/084467 [Registered on: 09/04/2025] Trial Registered Prospectively
Last Modified On: 04/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Clinical Study to compare the Efficacy of Nashtapushpantaka Rasa and Rajahpravartini Vati in the treatment of Artavakshaya in females of Polycystic Ovarian Syndrome 
Scientific Title of Study   A Randomized Comparative Clinical Study to Evaluate the Efficacy of Nashtapushpantaka Rasa and Rajahpravartini Vati in the management of Artavakshaya in Polycystic Ovarian Syndrome 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Mamta Rani 
Designation  PhD scholar 
Affiliation  Institute of Ayurveda Studies & Research SKAU Kurukshetra 
Address  PhD Scholar Department of Prasuti Tantra and Stri Roga Institute of Ayurveda Studies & Research Faculty of Ayurveda Shri Krishna AYUSH university Kurukshetra Haryana
Assistant Professor Department of PTSR MSM Institute of Ayurveda BPS Mahila Vishwavidyalaya Khanpur Kalan Sonepat Haryana
Kurukshetra
HARYANA
136118
India 
Phone  9350952506  
Fax    
Email  docmamta18@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Jitesh Kumar Panda 
Designation  Professor 
Affiliation  Institute of Ayurveda Studies & Research SKAU Kurukshetra 
Address  Guide Chairperson PG Department of Prasuti Tantra and Stri Roga Institute of Ayurveda Studies & Research Faculty of Ayurveda Shri Krishna AYUSH university Kurukshetra Haryana

Kurukshetra
HARYANA
138118
India 
Phone  9896033056  
Fax    
Email  drjk67@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Gati Krushna Panda 
Designation  Associate Professor 
Affiliation  MSM Institute of Ayurveda BPS Mahila Vishwavidyalaya Khanpur Kalan Sonepat Haryana 
Address  Co- Guide Head of department Department of PTSR MSM Institute of Ayurveda BPS Mahila Vishwavidyalaya Khanpur Kalan Sonepat Haryana

Sonipat
HARYANA
131305
India 
Phone  9996454885  
Fax    
Email  dr_gatikrushna@rediffmail.com  
 
Source of Monetary or Material Support  
MSM Institute of Ayurveda BPSMV Khanpur Kalan Sonepat Haryana 
 
Primary Sponsor  
Name  Mamta Rani 
Address  Assistant Professor MSM Institute of Ayurveda BPSMV Khanpur Kalan Sonepat Haryana  
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrMamta Rani  MSM Institute of Ayurveda Hospital BPSMV Khanpur Kalan Sonepat  OPD No 29 Department of Prasuti Tantra and Stri Roga MSM Institute of Ayurveda Hospital BPSMV Khanpur Kalan Sonepat haryana
Sonipat
HARYANA 
9350952506

docmamta18@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee BPSMV Khanpur Kalan  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N914||Secondary oligomenorrhea. Ayurveda Condition: ARTAVAKSHAYAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Nashtapushpantaka Rasa, Reference: Bhaishjyaratnavali chapter67 shloka51 to 56, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 250(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 99 Days, anupAna/sahapAna: Yes(details: -lukewarm water), Additional Information: -99 days (28 days intervention -Gap of 5days- 28days- gap 5 days- 28 days-gap 5days)
2Comparator ArmDrugClassical(1) Medicine Name: Rajahpravartini Vati, Reference: Bhaishjyaratnavali chapter 67 shloka 58 to 60, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 250(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 99 Days, anupAna/sahapAna: Yes(details: -lukewarm water), Additional Information: -99 days (28 days intervention -Gap of 5days- 28days- gap 5 days- 28 days-gap 5days)
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  Females having PCOS assessed on Rotterdam criteria
-2outof3
-oligo-and or anovulation
-clinical and or biochemical signs of hyperandrogenism
-polycystic ovaries in USG
Patient is ready to provide signed informed consent
 
 
ExclusionCriteria 
Details  PCOS with heavy menstrual bleeding or menorrhagia or metrorrhagia.
Females less than 18 yrs. and more than 40 yrs. of age.
Females having primary amenorrhea.
Females having physiological secondary amenorrhea due to lactation.
Females with any organic pelvic lesions like fibroid uterus, adenomyosis, PID etc.
Females with hypo and hyper thyroidism.
Patients with chronic systemic illness.
Patients using oral contraceptive pills.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Changes in Menstrual cycle length intermenstrual period amount and quality of bleeding.
In USG changes in ovarian volume and polycystic appearance of ovary.
Changes in hormone levels serum FSH LH LH FSH ratio Prolactin testosterone etc
 
baseline and after 99 days
 
 
Secondary Outcome  
Outcome  TimePoints 
Changes in hirsutism based on Ferriman- Gallway score.
Changes in Quality of Life using PCOS-Qol Scale.
 
baseline and after 99 days
 
 
Target Sample Size   Total Sample Size="134"
Sample Size from India="134" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The Study is a Randomized, Open label, parallel group comparative clinical study to evaluate and compare the efficacy of Nashtapushpantaka Rasa 250 mg bd and Rajahpravartini Vati 250 mg bd for 99 days in 134 patients with Artavakshaya in Polycystic Ovarian Syndrome will be conducted at one centre in India. Primary Outcome measure will be Changes in Menstrual cycle length, intermenstrual period, amount and quality of bleeding. In USG changes in ovarian volume and polycystic appearance of ovary and Changes in hormone levels serum FSH, LH, Ratio LH FSH, Prolactin, testosterone etc. at baseline and after 99 days. Secondary outcome measure will be Changes in hirsutism based on Ferriman Gallway score and Changes in Quality of Life using PCOS Qol Scale at baseline and after 99 days.

 
Close